Andrew Offer - Jul 19, 2021 Form 4 Insider Report for Sight Sciences, Inc. (SGHT)

Role: Director
Signature: /s/ Jeremy Hayden, Attorney-in-Fact for Andrew Offer
Stock symbol: SGHT
Transactions as of: Jul 19, 2021
Transactions value $: $0
Form type: 4
Date filed: 7/19/2021, 08:17 PM
Previous filing: Jul 14, 2021

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	SGHT	Common Stock	Conversion of derivative security		+3.16K			3.16K	Jul 19, 2021	Direct	F1
transaction	SGHT	Common Stock	Conversion of derivative security		+2.23M	+1721.25%		2.36M	Jul 19, 2021	See footnote	F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	SGHT	Series C Preferred Stock	Conversion of derivative security		-1.58K	-100%		0	Jul 19, 2021	Common Stock	3.16K		Direct	F1
transaction	SGHT	Series A Redeemable Convertible Preferred Stock	Conversion of derivative security		-1.09M	-100%		0	Jul 19, 2021	Common Stock	2.17M		See footnote	F1, F2
transaction	SGHT	Series B Redeemable Convertible Preferred Stock	Conversion of derivative security		-25.9K	-100%		0	Jul 19, 2021	Common Stock	51.8K		See footnote	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The preferred stock has no expiration date and automatically converted into two shares of common stock upon the closing of the Issuer's initial public offering.
F2	These shares are held of record by Scientific Health Development II, Ltd. ("SHD II"). SHD Management, LLC is the manager of SHD II. The reporting person is the Chief Executive Officer of SHD Management, LLC and may be deemed to beneficially own the shares of common stock held by SHD II.